These findings indicated a diminished anti-tumor immune response in HCC patients with high Smad4 expression and highlighted a positive correlation between the CXCL10/CXCR3 and glycolysis and TNF-α production in CD8+ T cells. This evidence concerns the gene SMAD4 and hepatocellular carcinoma.